In order to consider SLC34A2 as a potential prognostic and predictive marker of oncological diseases, we performed an analysis of the mutation and expression of SLC34A2, and assessed their effect on the life expectancy of patients from cancer studies which are publicly available online. This evidence concerns the gene SLC34A2 and cancer.